文献速递造血干细胞移植与细胞治疗白血病

没食子酸增强造血干细胞移植后T细胞的移植物抗白血病效应而不加重移植物抗宿主病

Gallic acid enhances GVL effects of T cells without exacerbating GVHD after haematopoietic stem cell transplantation.
PubMed 文献 · Br J Haematol · 2024-10-29

该研究在体外和白血病小鼠模型中证实,天然膳食化合物没食子酸(GA)可增强T细胞介导的移植物抗白血病(GVL)效应,表现为T细胞活化和细胞毒性细胞因子分泌增加、AML细胞凋亡、白血病小鼠生存延长和白血病细胞浸润减少;GA通过激活MAPK和NF-κB通路发挥作用,且不加速移植物抗宿主病(GVHD)进展。

要点

  • 没食子酸(GA)在体外增强T细胞活化及细胞毒性细胞因子分泌,促进AML细胞凋亡。
  • 在非照射白血病小鼠模型中,GA延长白血病小鼠生存并减少白血病细胞浸润。
  • GA通过激活MAPK和NF-κB通路增强GVL效应,且不加速GVHD进展。

核心结论

  • 没食子酸(GA)可增强T细胞的移植物抗白血病(GVL)效应而不加重移植物抗宿主病(GVHD),为改善造血干细胞移植后患者结局提供思路。

研究设计与样本

  • 研究采用体外共培养系统和non-irradiated白血病小鼠模型,评估没食子酸(GA)对T细胞介导的GVL效应及GVHD的影响。

主要发现

  • GA处理的T细胞在体外共培养系统中活化和细胞毒性细胞因子分泌增加,导致AML细胞凋亡。
  • 在非照射白血病小鼠模型中,GA治疗延长白血病小鼠生存并减少白血病细胞浸润。
  • GA治疗增加T细胞活化和肿瘤坏死因子-α分泌。
  • 整合转录组和蛋白质组分析表明,GA通过激活MAPK和NF-κB通路增强T细胞介导的GVL效应;单独阻断这些通路削弱GA在AML模型小鼠中的保护作用。
  • GA给药在小鼠模型中未加速移植物抗宿主病(GVHD)进展。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Allogeneic haematopoietic stem cell transplantation (allo-HSCT) is an effective therapy for acute myeloid leukaemia (AML), predominantly due to its potent graft-versus-leukaemia (GVL) effect. However, leukaemia relapse remains a major obstacle to the success of allo-HSCT. In this study, we demonstrated that gallic acid (GA), a natural dietary compound, can enhance T-cell-mediated GVL effects both in vitro and in vivo. GA-treated T cells exhibited increased activation and elevated secretion of cytotoxic cytokines, leading to the apoptosis of AML cells in co-culture systems in vitro. In a non-irradiated leukaemia mouse model, we showed that GA treatment prolonged the survival of leukaemic mice and reduced leukaemia cell infiltration. Further analysis revealed that GA treatment increased T-cell activation and tumour necrosis factor-α secretion. Moreover, integrated transcriptomic and proteomic analyses indicated that GA augments T-cell-mediated GVL effects through the activation of the MAPK and NF-κB pathways. Blocking these pathways individually diminished the protective effect of GA in AML model mice. Importantly, GA administration did not accelerate graft-versus-host disease (GVHD) progression in a mouse model. In conclusion, our study revealed that GA can enhance the GVL effects of T cells without exacerbating GVHD, offering insights into its potential to improve outcomes for patients after HSCT.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Huang Q, Jiang X, Wang B, et al. Gallic acid enhances GVL effects of T cells without exacerbating GVHD after haematopoietic stem cell transplantation. Br J Haematol. 2024. PMID: 39472128. doi:10.1111/bjh.19863

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。